BrainStorm Cell Therapeutics

Stacy Lindborg, Ph.D., Executive Vice President and Head of Global Clinical Research

New York City, NY

Virtual Presentation

BrainStorm Cell Therapeutics is a clinical-stage, publicly-traded, biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the treatment of highly debilitating neurodegenerative diseases.

By using this website you agree to accept our Privacy Policy and Terms & Conditions